Clinical Trials Browser

Klatskin Tumor

NCT06109779 2026-03-04

Rilvegostomig + Chemotherapy as Adjuvant Therapy for Biliary Tract Cancer After Resection (ARTEMIDE-Biliary01)

Phase 3 Active not recruiting

757 enrolled

Gastrointestinal

Bile Duct Neoplasms, Biliary Tract Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma, Klatskin Tumor

NCT06178588 2026-02-24

Sacituzumab Govitecan for the Treatment for Patients With Locally Advanced, Recurrent, or Metastatic Cholangiocarcinoma

Phase 2 Active not recruiting

15 enrolled

Gastrointestinal

Cholangiocarcinoma, Klatskin Tumor

NCT05430698 2026-02-09

PD-1 Antibody Plus GEMOX as Postoperative Adjuvant Therapy in Perihilar Cholangiocarcinoma

Phase 2 Recruiting

62 enrolled

Gastrointestinal

Klatskin Tumor

NCT06739252 2026-01-28

Perioperative Treatment of High-risk Resectable CCA With HAIC Plus A+T: Neobrave CCA

Phase 2 Terminated

1 enrolled

Gastrointestinal

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma, Klatskin Tumor

NCT07326189 2026-01-16

PHAE-PHCC

Phase NA Not yet recruiting

33 enrolled

Gastrointestinal

Klatskin Tumor

NCT03104569 2025-12-26

Effect of 37℃ Non-ionic Contrast Agent During ERCP Procedure in Hilar Cholangiocarcinoma

Phase NA Not yet recruiting

100 enrolled

Gastrointestinal

Cholangitis, Klatskin Tumor

NCT06420349 2025-12-22

NXP800 for the Treatment of Patients With Advanced or Metastatic Cholangiocarcinoma

Phase 1 Terminated

7 enrolled

Gastrointestinal

Cholangiocarcinoma, Klatskin Tumor

NCT05024513 2025-12-18

Biliary Drainage Plus HAIC in Locally Advanced pCCA

Phase 2 Completed

127 enrolled

Gastrointestinal

Klatskin Tumor

NCT06850753 2025-08-21

SURE-LT

Phase NA Recruiting

15 enrolled

Gastrointestinal

Klatskin Tumor

NCT04993131 2025-07-31

TESLA II

Phase NA Recruiting

15 enrolled

Gastrointestinal

Bile Duct Neoplasms, Klatskin Tumor

NCT03377179 2025-07-23

A Study of ABC294640 Alone and in Combination With HCQ Sulfate in the Treatment of Advanced Cholangiocarcinoma

Phase 2 Completed

65 enrolled

Gastrointestinal

Cholangiocarcinoma, Klatskin Tumor

NCT06493734 2025-07-15

STRONG II

Phase NA Recruiting

30 enrolled

Gastrointestinal

Klatskin Tumor

NCT07030140 2025-06-22

Phase II Study of Neoadjuvant Tislelizumab Plus Radiotherapy and GP Chemotherapy for Borderline/Unresectable Hilar Cholangiocarcinoma

Phase 2 Not yet recruiting

38 enrolled

Gastrointestinal

Bile Duct Neoplasms, Biliary Tract Neoplasms, Cholangiocarcinoma, Klatskin Tumor

NCT05239169 2025-05-01

Immunotherapy With Durva and Treme With or Without Capecitabine in Adjuvant Treatment for Biliary Tract Cancer

Phase 2 Completed

40 enrolled

Gastrointestinal

Biliary Tract Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma, Klatskin Tumor

NCT06923475 2025-04-11

NEODISCO

Phase 2/3 Not yet recruiting

150 enrolled

Gastrointestinal

Cholangiocarcinoma, Klatskin Tumor

NCT05551299 2025-03-27

CARP

Phase 4 Recruiting

258 enrolled

Gastrointestinal

Bile Duct Neoplasms, Klatskin Tumor

Clinical Trials

LITALHICA

Rilvegostomig + Chemotherapy as Adjuvant Therapy for Biliary Tract Cancer After Resection (ARTEMIDE-Biliary01)

Sacituzumab Govitecan for the Treatment for Patients With Locally Advanced, Recurrent, or Metastatic Cholangiocarcinoma

PD-1 Antibody Plus GEMOX as Postoperative Adjuvant Therapy in Perihilar Cholangiocarcinoma

Perioperative Treatment of High-risk Resectable CCA With HAIC Plus A+T: Neobrave CCA

PHAE-PHCC

Effect of 37℃ Non-ionic Contrast Agent During ERCP Procedure in Hilar Cholangiocarcinoma

NXP800 for the Treatment of Patients With Advanced or Metastatic Cholangiocarcinoma

Biliary Drainage Plus HAIC in Locally Advanced pCCA

SURE-LT

TESLA II

A Study of ABC294640 Alone and in Combination With HCQ Sulfate in the Treatment of Advanced Cholangiocarcinoma

STRONG II

Phase II Study of Neoadjuvant Tislelizumab Plus Radiotherapy and GP Chemotherapy for Borderline/Unresectable Hilar Cholangiocarcinoma

Immunotherapy With Durva and Treme With or Without Capecitabine in Adjuvant Treatment for Biliary Tract Cancer

NEODISCO

CARP